Europe approves J&J single shot Covid-19 vaccine; some 200 million doses pledged by end of year

Europe approved Johnson & Johnson's single-dose COVID-19 vaccine on Thursday and is expected to be delivered in a month. The COVID-19 shot is the fourth to be endorsed for use in the European Union after vaccines from Pfizer-BioNTech, AstraZeneca-Oxford University, and Moderna, and is recommended for those over 18 years of age, the European Medicines Agency (EMA) said.